Science & Enterprise subscription

Follow us on Twitter

  • An engineering-psychology team is developing a system connecting virtual reality with brain signals in real time t… https://t.co/mF081BrzQX
    about 13 hours ago
  • New post on Science and Enterprise: Virtual Reality Coupled with EEG for Autism https://t.co/PTQ1ZTFwia #Science #Business
    about 13 hours ago
  • Sherlock Biosciences Inc., a new enterprise offering medical diagnostics based on the genome-editing technology Cri… https://t.co/KDxJiTUw7L
    about 1 day ago
  • New post on Science and Enterprise: Crispr Diagnostics Company Launches with $35M Funding https://t.co/FMgCNeOrnS #Science #Business
    about 1 day ago
  • Drug maker Celgene is gaining access to an artificial intelligence platform developed by Exscientia Ltd, to find tr… https://t.co/atz6p5EQAn
    about 2 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Hospital Network Formed for Childhood Cancer Immunotherapies

T-cells illustration

A network of academic children’s medical centers is being formed to expand access to clinical trials testing immunotherapy treatments for childhood cancer. . . . → Read More: Hospital Network Formed for Childhood Cancer Immunotherapies

Crowdfunding Found Supporting Dubious Stem Cell Clinics

Crowdfunding graphic

More people now use crowdfunding campaigns to raise money to cover families’ medical costs, but the technique is also used to support treatments from stem cell clinics that exaggerate their outcomes and minimize their risks. . . . → Read More: Crowdfunding Found Supporting Dubious Stem Cell Clinics

Self-Service A.I. Offered for Pathologists

A company in Finland is beginning a service that allows pathologists and researchers the ability to design their own artificial intelligence algorithms without writing code, for analyzing visual images of tissue samples. . . . → Read More: Self-Service A.I. Offered for Pathologists

Institute, Company Studying Neuro Disease Proteins

The Montreal Neurological Institute and Thermo Fisher Scientific are beginning a study of 30 proteins implicated in neurodegenerative diseases to validate related antibodies and reagents for advancing treatments. . . . → Read More: Institute, Company Studying Neuro Disease Proteins

Highly Stretchable Sensors Devised for Wearable Devices

Engineers in Canada developed graphene sensors with a great deal of flexibility that can measure fine human movements and minute functions for wearable medical devices, and be made with an economical process. . . . → Read More: Highly Stretchable Sensors Devised for Wearable Devices

Radiation, Biotech Companies Partner on Scar Therapy

Two companies taking different approaches to treating keloids — visible raised skin scars — are integrating their therapies to develop an anticipated treatment that removes and prevents the recurrence of these scars. . . . → Read More: Radiation, Biotech Companies Partner on Scar Therapy

Brain Wave Data Harnessed for Open-Source Brain Model

A lab in Germany created a technique for discovering a person’s neurological patterns from brain waves captured with a headset and simulated with population-wide brain data run on open-source software. . . . → Read More: Brain Wave Data Harnessed for Open-Source Brain Model

Retinal Scanner Detects Early Vision Problems

A Canadian engineering lab designed a retinal scanner that helps diagnose eye diseases in their early stages, often well before vision loss occurs. . . . → Read More: Retinal Scanner Detects Early Vision Problems

Zymeworks, Janssen in $1.45B Antibody Licensing Deal

Janssen Biotech, a division of drug maker Johnson & Johnson, is acquiring technologies that make it possible to create synthetic antibodies that hit multiple targets. . . . → Read More: Zymeworks, Janssen in $1.45B Antibody Licensing Deal

Project to Develop Universal Flu Vaccine

An initiative joining academic, private, and national labs is designing a vaccine that covers all influenza strains, with clinical studies expected to begin early next year. . . . → Read More: Project to Develop Universal Flu Vaccine